Patents by Inventor Huaxiang Fang

Huaxiang Fang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220064141
    Abstract: A compound represented by formula I, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a tautomer thereof, or a hydrate thereof, or a solvate thereof, or a metabolite thereof, or a prodrug thereof. R1-R5 and group A are as defined in the description. The compound is used for the preparation of drugs for treating diseases caused by KRAS G12C mutation and for treating and/or preventing cancers.
    Type: Application
    Filed: January 19, 2020
    Publication date: March 3, 2022
    Inventors: Huaxiang Fang, Fangfang Li, Yong Xu, Lu Huang, Jinfeng Tao